Dr. Charles Kim, MD

Dr. Kim practices at Center for Sight of Stockton a Medical Corporation in Stockton, California.

Dr. Kim's NPI, 1104242924, was assigned on March 18, 2014. Dr. Kim graduated from UC Davis School of Medicine in 2010. Dr. Kim holds California license A142099.

Dr. Kim's primary practice is Center for Sight of Stockton a Medical Corporation, at 1899 W March Ln, Stockton, CA 95207 in San Joaquin County. The practice phone is (209) 623-4700.

Dr. Kim's primary practice is Center for Sight of Stockton a Medical Corporation in Stockton, California. Dmand AI also links Dr. Kim to 1 group practice or clinic and 1 medical group, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Kim practices. Vendor and product names are available with a free account.

Ophthalmic plastic and reconstructive surgery is Dr. Kim's primary specialty in the NPI Registry, under taxonomy code 207WX0200X. Dr. Kim is board certified in ophthalmology by the American Board of Ophthalmology. Dmand AI has Dr. Kim's licenses on file in 3 states: California, New Jersey and Pennsylvania.

Dmand AI lists age-related macular degeneration, cataract, cataract surgery with lens implant, conjunctivitis, dry eye, eye infection or inflammation, eyelid inflammation and glaucoma among the conditions Dr. Kim treats.

CMS data shows 1,498 Medicare services from Dr. Kim across 13 procedure codes in 2024, for 551 Medicare patients. Medicare paid $118,356 for them.

CMS counts 551 Medicare patients who saw Dr. Kim in 2024. The largest group is 65 to 74, with 277 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 66% are also on Medicaid. Their average risk score is 1.39, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Dr. Kim's median patient age at 59, with 65% women.

In 2024, Dr. Kim wrote 1,677 Medicare Part D claims for 466 patients. 67% of them were for generic drugs. CMS names the drug for 1,616 of them, across 17 drugs with 11 or more claims each, at $102,398 in total drug cost. In 2023, CMS named 1,616 claims across 16 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 93 out of 100 for Dr. Kim for performance year 2024, reported as part of a group. Dr. Kim accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS counts 19 procedures of cataract surgery by Dr. Kim, more than 43% of the clinicians it reports for that procedure.

Melanoma (skin cancer) excision: 1 to 10 procedures (CMS shows small counts as a range)

Dmand AI links 15 papers to Dr. Kim, published from 2008 to 2017. 2013 was the busiest year, with 2. The most frequent topics are Dacryocystorhinostomy, Endoscopy and Tomography, X-Ray Computed. Dr. Kim has published most often in Orbit. Dr. Kim's most frequent co-authors are Charles Kim, MD, Ashutosh Kacker, MD and Jacqueline R. Carrasco, MD.

CMS Open Payments shows 67 general payments to Dr. Kim from 15 drug and device companies from 2017 to 2025. Speaker and faculty fees make up the largest share, 67% of the total. Amgen Inc. paid the most, $15,726.

Dr. Kim graduated from UC Davis School of Medicine in 2010.

Dr. Kim is in network with 20 carriers, including Aetna, Blue Cross Blue Shield of Michigan and HCSC. HMO plans come from the most carriers, 11. Check the plan with the practice before a visit.